adenosine has been researched along with Parkinson Disease, Secondary in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brambilla, R; Cavaccini, A; Cerovic, M; Greco, B; Gritti, M; Morella, I; Nazzaro, C; Saintot, PP; Tonini, R; Trusel, M | 1 |
| Ahmad, M; Islam, F; Saleem, S; Sayeed, I; Siddiqui, A; Zafar, KS | 1 |
| Morelli, M | 1 |
| Kase, H; Koga, K; Kurokawa, M; Kuwana, Y; Nakamura, J | 1 |
| Jenner, P; Kanda, T; Kuwana, Y; Tashiro, T | 1 |
| Fukuda, T; Iwata, S; Kaseda, S; Nomoto, M; Shimizu, T | 1 |
| Aoyama, S; Borrelli, E; Kase, H | 1 |
1 review(s) available for adenosine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Adenosine A2A antagonists: potential preventive and palliative treatment for Parkinson's disease.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Caffeine; Central Nervous System Stimulants; Humans; Neuroprotective Agents; Palliative Care; Parkinson Disease; Parkinson Disease, Secondary; Rats | 2003 |
6 other study(ies) available for adenosine and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control.
Topics: Adenosine; Animals; Cerebral Cortex; Corpus Striatum; Dopamine; Dopaminergic Neurons; Excitatory Postsynaptic Potentials; Long-Term Synaptic Depression; MAP Kinase Signaling System; Mice; Motor Activity; Neuronal Plasticity; Parkinson Disease, Secondary; Receptor, Adenosine A1; Small-Conductance Calcium-Activated Potassium Channels; Substantia Nigra | 2015 |
Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences.
Topics: Adenosine; Animals; Behavior, Animal; Brain Chemistry; Catalase; Dopamine; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Lipid Peroxidation; Male; Motor Activity; Oxidation-Reduction; Oxidopamine; Parkinson Disease, Secondary; Postural Balance; Rats; Rats, Wistar; Sympathomimetics | 2003 |
Adenosine A2a receptor-mediated modulation of striatal acetylcholine release in vivo.
Topics: Acetylcholine; Adenosine; Animals; Corpus Striatum; Drug Combinations; GABA Antagonists; Male; Muscimol; Oxidopamine; Parkinson Disease, Secondary; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Reference Values | 1996 |
Adenosine A2A receptors modify motor function in MPTP-treated common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine; Animals; Callithrix; Dopamine; Female; Male; Motor Activity; Movement; Parkinson Disease, Secondary; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Receptor, Adenosine A2A; Receptors, Purinergic P1 | 1998 |
Metabolism of adenosine increase in the striatum in common marmoset parkinsonism induced by MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine; Animals; Callithrix; Corpus Striatum; Extracellular Space; Inosine; Microdialysis; Parkinson Disease, Secondary | 1999 |
Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.
Topics: Adenosine; Animals; Antihypertensive Agents; Antineoplastic Agents; Enkephalins; Gait; Gene Expression; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Parkinson Disease, Secondary; Phenethylamines; Purinergic P1 Receptor Antagonists; Purines; Radioligand Assay; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; RNA, Messenger; Substance P; Tritium | 2000 |